Logo image of CJET

CHIJET MOTOR CO INC (CJET) Stock Fundamental Analysis

NASDAQ:CJET - Nasdaq - KYG4465R1112 - Common Stock - Currency: USD

1.7  -0.01 (-0.58%)

Fundamental Rating

0

CJET gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 37 industry peers in the Automobiles industry. CJET may be in some trouble as it scores bad on both profitability and health. CJET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CJET had negative earnings in the past year.
In the past year CJET has reported a negative cash flow from operations.
CJET Yearly Net Income VS EBIT VS OCF VS FCFCJET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -9.98%, CJET perfoms like the industry average, outperforming 54.05% of the companies in the same industry.
Industry RankSector Rank
ROA -9.98%
ROE N/A
ROIC N/A
ROA(3y)-7.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJET Yearly ROA, ROE, ROICCJET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CJET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJET Yearly Profit, Operating, Gross MarginsCJET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

CJET does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CJET has more shares outstanding
Compared to 1 year ago, CJET has a worse debt to assets ratio.
CJET Yearly Shares OutstandingCJET Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
CJET Yearly Total Debt VS Total AssetsCJET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -2.69, we must say that CJET is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CJET (-2.69) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.69
ROIC/WACCN/A
WACC4.84%
CJET Yearly LT Debt VS Equity VS FCFCJET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

CJET has a Current Ratio of 0.11. This is a bad value and indicates that CJET is not financially healthy enough and could expect problems in meeting its short term obligations.
CJET's Current ratio of 0.11 is on the low side compared to the rest of the industry. CJET is outperformed by 91.89% of its industry peers.
A Quick Ratio of 0.09 indicates that CJET may have some problems paying its short term obligations.
The Quick ratio of CJET (0.09) is worse than 86.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.09
CJET Yearly Current Assets VS Current LiabilitesCJET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

0

3. Growth

3.1 Past

CJET shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.55%, which is quite impressive.
CJET shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.03%.
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.55%
Revenue 1Y (TTM)-27.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJET Yearly Revenue VS EstimatesCJET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CJET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJET Price Earnings VS Forward Price EarningsCJET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CJET Per share dataCJET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CJET does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHIJET MOTOR CO INC

NASDAQ:CJET (8/14/2025, 12:45:40 PM)

1.7

-0.01 (-0.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners4.87%
Ins Owner ChangeN/A
Market Cap52.51M
AnalystsN/A
Price TargetN/A
Short Float %0.1%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0.22
BVpS-5.79
TBVpS-13.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.74%
Cap/Sales 15.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.09
Altman-Z -2.69
F-Score3
WACC4.84%
ROIC/WACCN/A
Cap/Depr(3y)15.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.5%
OCF growth 3YN/A
OCF growth 5YN/A